We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Risk & Pharmacovigilance MasterClass 2.0

The focus of this two-day masterclass will be on providing an update of ongoing medicines' risk and signal management with an emphasis on current signal detection and management guidelines and tools as well as the impact of GDPR.

GLC Europe is excited to welcome you to the Risk & Pharmacovigilance MasterClass on the 19 - 20 September 2019 in the historical city of Vienna, Austria. The MasterClass will be led by Dimitris Zampatis, Associate director, Signal and Risk Management Process at Merck Biopharma, Germany.

The focus of this two-day masterclass will be on providing an update of ongoing medicines' risk and signal management. Participants will also have the opportunity to get an insight on the current signal detection and management guidelines and tools. During this training, an outlook of current and future challenges in pharmacovigilance focusing on the impact of the General Data Protection Regulation (GDPR) in May 2018 will be given and discussed.

By the end of this MasterClass, participants will:

  • Learn all the details about the RMP Structure and compilation
  • Discover the risk minimization measures
  • Have a closer look on the signal detection and the MAH experience in EVDAS
  • Get to know the EU guidelines and the authorities’ expectation on signal management

For the training description, detailed trainer profile and training program, please request the Training Agenda!

When

19 Sep 2019 @ 08:00 am

20 Sep 2019 @ 05:45 pm

Duration: 1 days, 9 hours


Where

Austria Trend Parkhotel Schönnbrunn

10-16 Hietzinger Hauptstraße

1130 Wien

Austria


Organised by

GLC Europe

Premium Events in Health

Recent Publications in Health

Recent Videos in Health

Recent News in Health

The tools and knowledge to end #endHIV and #AIDS exist. We need to keep using them. How are Europe & central Asi… https://t.co/vVcXOX3cCt

@ECDC_EU - 22 Jul 2019 15:58

@ncdalliance @WHO @WHOatEU What happens when you stop smoking? Evidence shows that you start to see the benefits af… https://t.co/HrzhCEvwfE

@WHO_Europe - 22 Jul 2019 13:16

Check out the agenda of this week’s meeting of the Committee for Human #Medicines (#CHMP): https://t.co/Aw22aitKeq

@EMA_News - 22 Jul 2019 13:05

Recent Speakers in Health

Premium EventsLearn more ..